Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Forte Biosciences (FBRX) Accumulated Expenses (2016 - 2020)

Historic Accumulated Expenses for Forte Biosciences (FBRX) over the last 5 years, with Q3 2020 value amounting to $898000.0.

  • Forte Biosciences' Accumulated Expenses fell 9225.93% to $898000.0 in Q3 2020 from the same period last year, while for Sep 2020 it was $898000.0, marking a year-over-year decrease of 9225.93%. This contributed to the annual value of $343000.0 for FY2019, which is 9738.05% down from last year.
  • Per Forte Biosciences' latest filing, its Accumulated Expenses stood at $898000.0 for Q3 2020, which was down 9225.93% from $866000.0 recorded in Q2 2020.
  • Over the past 5 years, Forte Biosciences' Accumulated Expenses peaked at $13.1 million during Q4 2018, and registered a low of $343000.0 during Q4 2019.
  • Its 5-year average for Accumulated Expenses is $7.5 million, with a median of $8.0 million in 2017.
  • Per our database at Business Quant, Forte Biosciences' Accumulated Expenses soared by 6745.85% in 2018 and then crashed by 9738.05% in 2019.
  • Forte Biosciences' Accumulated Expenses (Quarter) stood at $5.4 million in 2016, then surged by 49.35% to $8.1 million in 2017, then soared by 61.26% to $13.1 million in 2018, then plummeted by 97.38% to $343000.0 in 2019, then soared by 161.81% to $898000.0 in 2020.
  • Its Accumulated Expenses stands at $898000.0 for Q3 2020, versus $866000.0 for Q2 2020 and $6.0 million for Q1 2020.